Two Sigma Advisers’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
Other funds holding NXTC
SI
LGM
AAA
O
CCC
TCM
LFCM
Two Sigma Advisers's NXTC Position: Q2 2024 in Review
Two Sigma Advisers sold out of NextCure (NXTC) in Q2 2024, closing a stake of 4,808 shares — an estimated $129K sold.
Two Sigma Advisers first reported a position in NXTC in Q2 2020 and held it in 16 quarters. The position peaked at $1.52M in Q3 2020. 48 funds tracked by Wall St. Rank hold NXTC as of Q2 2024.
- Two Sigma Advisers reported no remaining NextCure position as of Q2 2024 after selling out during the quarter.
- Two Sigma Advisers sold 4,808 NextCure shares in Q2 2024, an estimated $129K.
- Two Sigma Advisers first reported a position in NextCure in Q2 2020 and held it in 16 quarters.
- Two Sigma Advisers's NextCure position peaked at $1.52M in Q3 2020.
- 48 funds tracked by Wall St. Rank held NextCure as of Q2 2024.
Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.